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1. Introduction 
Several observations have indicated preferential 
accumulation of cadmium in the liver and kidney 
when animals were administered the metal by either 
peroral or parenteral route [ 1,2]. Most of the cadmium 
thus accumulated in the organs exists bound to a 
low molecular weight protein [3,4] . The cadmium 
binding protein has several characteristics which 
suggest he protein to be closely related to metallo- 
thionein originally detected in the horse kidney [5] . 
It is also remarkable that the protein appeared to 
be induced rapidly in the liver upon cadmium loads 
[6] . However, the biological significance of those 
observations has not been established yet. 
It is generally accepted that vitamin D must be 
hydroxylated on C-25 position in the liver and sub- 
sequently on C-l position in the kidney before it 
can function on bone and intestine [7]. 
We found that I-hydroxylation reaction of 
25OHDs in chick kidney mitochondria was com- 
pletely inhibited in the presence of 0.1 mM of 
cadmium in vitro [S] , but that the I-hydroxylation 
reaction occurred in vivo even in the animals loaded 
with large amounts of oral cadmium [ 14,151. 
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In this study, we intend to clarify the significance 
of the discrepancy between the in vivo and the in 
vitro experiment. Evidence is shown that metallo- 
thionein in the kidney is involved in the prevention 
observed in vivo against the cadmium-induced 
inhibition of the vitamin D activation. 
2. Materials and methods 
2.1. Animals and preparations of mitochondria 
One-day old white Leghorn cockerel chicks were 
maintained on a vitamin D deficient purified soy 
protein diet [9] containing 1.2% calcium for 2 weeks 
and then on the same vitamin D deficient diet 
containing 0.1% calcium for another 2 weeks. After 
the feeding for 4 weeks in total, the chicks were 
killed by decapitation. Kidney mitochondria free 
from heavy contamination of calcium were prepared 
as described earlier [8] . Mitochondrial protein was 
assayed by the method of Gornall et al. [lo] . 
Abbreviations used : 25 -OH-Da, 25 -hydroxycholecalciferol; 
1,25-(OHh-D3,1,25dihydroxycholecalciferol; 
24,25-(0H)z-D3,24,25-dihydroxycholecalciferol. 
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2.2. Preparation and characterization of cadmium 
binding protein j?om kidney 
Cadmium chloride (3 mg/kg body weight) was 
injected subcutaneously to three male rabbits (3 kg) 
once a week for 3 weeks. Two months after the last 
injection the rabbits were killed, and the kidneys 
were removed, rinsed and homogenized in 60 ml of 
0.05 M phosphate buffer, pH 7.0, in a chilled Waring 
blender. The homogenate was centrifuged at 
100 000 g for 60 min at 4°C. The supernatant, 
adjusted to pH 8.6 by the addition of 1 N NaOH, 
was applied to a column of Sephadex G 75 (5 X 85 
cm) equilibrated with 0.01 M Tris-HCl buffer, 
pH 8.6, containing 0.01% NaNs. The elution was 
performed with the same buffer. The cadmium-con- 
taining protein, recovered in a single peak, concen- 
trated by ultrafiltration on Diafilter UM-2 (Amicon) 
and desalted through a column of Sephadex G 25. 
The desalted material was further purified by a 
column of DEAE-Sephadex A 25 equilibrated with 
0.05 M Tris-HCl buffer, pH 8.6. The column was 
eluted with a linear Tris-HCl gradient, obtained by 
running 1 litre of 0.25 M Tris-WC1 buffer, pH 8.6, 
from a reservoir chamber into a mixing chamber 
containing 1 litre of 0.05 M Tris-HCl buffer, pH 8.6. 
The purified cadmium binding protein was hydrol- 
yzed with 6 N HCl at 110°C for 24,48 and 72 hr, 
and its ammo acid composition was analyzed by 
means of an amino acid analyzer (JEOL 6AH). 
2.3. Determination of in vitro production of 
1,25-(OH/2-D3 and 24,25_10H)2-D3 from 
25OH-D3 
In a 25 ml Erlenmeyer flask, mitochondria (7.0 mg 
of protein) were preincubated in air for 5 min at 
30°C in 1 ml of a solution of Gray et al. [8,11], to 
which 0.2 mM of CaCls and graded concentrations 
of CdCIa or the purified cadmium binding protein 
were added as indicated in the text. The reaction 
was started with the addition of 770 ng (0.14 /Kc) of 
[26,27-3H]-25-OH-D3 (Amersham, Buckinghamshire, 
England), and stopped 20 min thereafter by the 
addition of 10 ml of a mixture of methanol and 
chloroform (2: 1 v/v). Extraction was performed as 
reported by Gray et al. [I I] . Chromatography of the 
extracts was carried out on a 1 X 30 cm column of 
Sephadex LH 20 using a solvent of 65% chloroform- 
35% hexane according to the method of Holick and 
DeLuca [ 121. Amounts of each vitamin D3 metabolite 
produced in vitro were calculated, as described 
earlier [8], from the radioactivities of the respective 
metabolites and the specific activity of the isotope. 
Table 1 
Amino acid composition of metallothionein solated from the rabbit kidney 
Amino acid 
Observed residues/mole 
Time of hydrolysis 
24 hr 48 hr 72 hr mean 
Calculated 
residues/ 
mole* 
Aspartic acid 8.78 9.48 8.86 9.04 9 
Threonine 4.42 4.38 4.26 4.46** 5 
Serine 8.32 7.90 7.34 8.90** 9 
Glutamic acid 4.12 4.14 4.12 4.12 4 
Protine 7.22 6.30 6.50 6.68 7 
Glycine 7.46 7.44 7.44 7.44 7 
Alanine (16) (16) (16) (I61 16 
Cysteic acid*** 29.50 30 
Methionine 1.64 1.62 1.52 1.60 2 
Isoleucine 1.04 1.16 1.12 1.12 1 
Lysine 12.28 12.60 12.26 12.38 12 
Calculated molecular weight of thionein 10 795 
Cadmium (Ccp/mg of metallothionein) 77.18 I 
Zinc (Mg/mg of metallothionein) 7.18 1 
* Calculated on the basis of 16 residues of aIanine/mole. 
** Extrapolated to the vahre at zero hour. 
*** Treated with performic acid. 
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Fig. 1. Sephadex LH-20 chromatographic profiles of chloroform extracts of mitochondrial suspension incubated with 770 ng of 
[3H] 25-OH-Da in the presence of 0.025 mM CdClz(A) or 0.5 mM of cadmium in the met,aBothionein (B). Columns were 
eluted using a solvent of 65% chloroform-35% hexane. Three ml fractions were collected automatically into liquid scintillation 
counting vials and evaporated to dryness under a stream of air. The radioactivity was determined using a toluene counting 
solution [ 121 and a Packard Model 3385 liquid scintillation spectrometer. The position of elution of vitamin D3 metabolites 
was determined with standards of radioactive 25-OH-Da, 1,25-(OH)z-Ds and 24,25-(OH)a-Da as previously described [12]. 
3. Results 
The cadmium-binding protein isolated from the 
rabbit kidney was unique in that it had an extremely 
high content of cysteine (calculated from the 
amounts of cysteic acid) and low content of 
aromatic amino acids (table 1). These features are 
similar to those of metallothioneins isolated from 
the rabbit, rat and human liver [3,4,13] . Therefore 
it is strongly indicated that the induced cadmium- 
binding protein in the kidney belongs to the group 
of metallothioneins which have been well character- 
ized in the sample extracted from the liver. This 
protein, when one assumes the molecular weight as 
10 000, contained 7 moles of cadmium and one 
mole of zinc per mole of apoprotein (table 1). 
The 25-OHDs-l-hydroxylase activity in chick 
kidney mitochondria was assayed in vitro in the 
presence of 0.2 mM calcium, since in our experi- 
mental system the maximal activity was always 
obtained with this concentration of calcium [8]. 
The mitochondria produced as much as 16.8 ng of 
1,25-(OH), -Ds per 20 min per mg protein (fig. 2). 
\ aa 
II1 1 3 10 50 (ppm) 
Cd concentration as CdCtz or Mctallotionein 
Fig. 2. Effects of cadmium of CdClz and metallothionein 
on the 25-OH-Da-1-hydroxylase activity in chick kidney 
mitochondria. Control value shows the amounts of 
1,25-(OH)z-Da produced in 20 min per mg of mitochon- 
drial protein in the absence of cadmium. Note that as little 
as 0.025 mM of CdClz inhibited the enzyme activity 
completely, while as much as 0.5 mM of cadmium in the 
metallothionein did not inhibit it. 
25 
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The addition of 0.025 mM of CdCla to the mito- 
chondrial suspension inhibited the I-hydroxylation 
almost completely. More than 94% of the radio- 
activity recovered was eluted as unchanged 25-OH-D3 
(fig. 1A). 
On the contrary, the addition of the concen- 
trations of the kidney cadmium-binding protein that 
contained from 0.01 to 0.5 mM (final concentration) 
of cadmium did not show any deleterious influence 
upon this enzyme reaction. Even when cadmium 
was introduced as the cadmium binding protein to 
a concentration as high as 0.5 mM, 1,25-(0H)a Ds 
was produced at the rate of 14.4 ng/mg protein/ 
20 min (fig. 1B and 2). 
4. Discussion 
The kidneys of the rats fed a diet containing 30 
and 300 ppm of cadmium for 3 weeks, had 9.7 and 
36.5 pg of cadmium per g of fresh weight [ 151. 
These values are equivalent to about 0.09 and 0.3 
mmoles per kilogram, respectively. The data shown 
in fig. 2 indicate that as little as 0.025 mM (2.8 ppm) 
of CdCla in vitro inhibited completely the activity 
of the 25-OH-Ds -l-hydroxylase in chick kidney 
mitochondria. Therefore, it would be expected that 
the I-hydroxylase activity in vivo could be completely 
abolished by the amount of cadmium accumulated 
in the kidney after the oral administration. Never- 
theless, the activation reaction of 25-OH-Ds pro- 
ceeded in vivo without appreciable hindrance even 
in the rats fed the diet containing 30 and 300 ppm 
of the cadmium for 3 weeks [14,15]. 
This discrepancy of in vivo and in vitro effects 
of cadmium on the 1-hydroxylation led us to examine 
the possibility that the metallothionein, induced by 
cadmium, might exert a preventive effect against the 
cadmium toxicity. The characteristic features of the 
cadmium binding protein isolated from the rabbit 
kidney support the assumption that the protein 
belongs to a group of metallothionein. In fact, at 
least 90% of the cadmium accumulated in the kidney 
is found to be bound to the cadmium-binding 
protein [15] . In view of the present results that 
cadmium bound to the binding protein was inert to 
the l-hydroxylation reaction, it seems reasonable to 
consider that the cadmium deposited in the kidney 
26 
as metallothionein is practically without effect on 
vitamin D metabolism. 
These data and discussion, though compiled from 
the experiments performed in three different species 
of animals, support strongly the suggestion that the 
metallothionein, induced by cadmium intake, is 
involved in the mechanism whereby cadmium 
toxicity is prevented in vivo. Though unsuccessful 
presently for technical reasons, the final conclusion 
will be obtained when the whole set of experiments 
are performed in a single species of animals. 
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